CYP11B2 gene haplotypes independently and in concurrence with aldosterone and aldosterone to renin ratio increase the risk of hypertension

Clinical Biochemistry

Volumn 43, Issue 1-2, 2010, Pages 136-141

  Nejatizadeh, Azim ^a   Kumar, Rahul ^a,d   Stobdan, Tsering ^a   Goyal, A K ^b   Gupta, Mohit ^c   Tyagi, S ^c   Jain, S K ^d   Pasha, M A Qadar ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b HINDU RAO HOSPITAL   (India)

^c G B PANT HOSPITAL   (India)

^d HAMDARD UNIVERSITY   (India)

Author keywords

Aldosterone levels; CYP11B2 gene; Hypertension; Polymorphisms

Indexed keywords

ALDOSTERONE SYNTHASE;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; MIDDLE AGED; POLYMORPHISM, GENETIC; RENIN;

EID: 72649101950     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.09.015     Document Type: Article

References (33)

1. Freel E.M., and Connell J.M.C. Mechanisms of hypertension: the expanding role of aldosterone. J. Am. Soc. Nephrol. 15 (2004) 1993-2001
2. Kawamoto T., Mitsuuchi Y., Toda K., et al. Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 1458-1462
3. Lifton R.P., Dluhy R.G., Powers M., et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat. Genet. 2 (1992) 66-74
4. Pascoe L., Curnow K.M., Slutsker L., et al. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8327-8331
5. Mitsuuchi Y., Kawamoto T., Miyahara K., et al. Congenitally defective aldosterone biosynthesis in humans: inactivation of the P-450C18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients. Biochem. Biophys. Res. Commun. 190 (1993) 864-869
6. Bassett M.H., Zhang Y., Clyne C., White P.C., and Rainey W.E. Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by steroidogenic factor-1. J. Mol. Endocrinol. 28 (2002) 125-135
7. Barbato A., Russo P., and Siani A. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population. J. Hypertens. 22 (2004) 1895-1901
8. Brand E., Kato N., Chatelain N., et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 32 (1998) 198-204
9. Staessen J.A., Wang J.G., Brand E., et al. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J. Hypertens. 19 (2001) 1349-1358
10. Pojoga L., Gautier S., Blanc H., et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am. J. Hypertens. 11 (1998) 856-860
11. Tsujita Y., Iwai N., Katsuya T., et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens. Res. 24 (2001) 105-109
12. Lim P.O., Macdonald T.M., Holloway C., et al. Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J. Clin. Endocrinol. Metab. 87 (2002) 4398-4402
13. White P.C., and Slutsker L. Haplotype analysis of CYP11B2. Endocr. Res. 21 (1995) 437-442
14. Rajput C., Makhijani K., Norboo T., et al. CYP11B2 gene polymorphisms and hypertension in highlanders accustomed to high salt intake. J. Hypertens. 23 (2005) 79-86
15. Paillard F., Chansel D., Brand E., et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. Hypertension 34 (1999) 423-429
16. Tamaki S., Iwai N., Tsujita Y., and Kinoshita M. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese. Hypertension 33 (1999) 266-270
17. Zhu H., Sagnella G.A., Dong Y., et al. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J. Hypertens. 21 (2003) 87-95
18. Matsubara M., Sato T., Nishimura T., et al. CYP11B2 polymorphisms and home blood pressure in a population-based cohort in Japanese: the Ohasama Study. Hypertens. Res. 27 (2004) 1-6
19. Rossi E., Regolisti G., Perazzoli F., et al. -344C/T polymorphism of CYP11B2 gene in Italian patients with idiopathic low renin hypertension. Am. J. Hypertens. 14 (2001) 934-941
20. Pojoga L., Gautier S., Blanc H., et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am. J. Hypertens. 11 (1998) 856-860
21. Nejatizadeh A., Kumar R., Stobdan T., et al. Significance of angiotensinogen gene haplotypes and genotypes combinations in hypertension. J. Hypertens. 26 (2008) 1094-1101
22. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 199;19:5444.
23. Fardella C.E., Rodriguez H., Montero J., et al. Genetic variation in P450C 11As in Chilean patients with low renin hypertension. J. Clin. Endocrinol. Metab. 81 (1996) 4347-4351
24. Mayosi B.M., Keavney B., Watkins H., and Farrall M. Measured haplotype analysis of the aldosterone synthase gene and heart size. Eur. J. Hum. Genet. 5 (2003) 395-401
25. Dempster A.P., Laird N.M., and Rubin D.B. Maximum likelihood from in complete data via the EM algorithm. J. R. Stat. Soc. 39 (1977) 1-38
26. White P.C. Mechanism of disease, disorders of aldosterone biosynthesis and action. N. Engl. J. Med. 331 (1994) 250-258
27. Davies E., Holloway C.D., Ingram M.C., et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 33 (1999) 703-707
28. Takeda Y., Furukawa K., Inaba S., Miyamori I., and Mabuchi H. Genetic analysis of aldosterone synthase in patients with idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 84 (1999) 1633-1637
29. Schunkert H., Hengstenberg C., Holmer S.R., et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure. Circulation 99 (1999) 2255-2260
30. Komiya I., Yamada T., and Takara M. Lys (173) Arg and 344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension. Hypertension 35 (2000) 699-703
31. Davies E., Holloway C.D., Ingram M.C., et al. An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects. Clin. Endocrinol. 54 (2001) 1-6
32. de Simone G., Tommaselli A.P., Rossi R., et al. Partial deficiency of adrenal 11 betahydroxylase: A possible cause of primary hypertension. Hypertension 7 (1985) 613-618
33. Honda M., Nowaczynski W., Guthrie G.P., et al. Response of several adrenal steroids to ACTH stimulation in essential hypertension. J. Clin. Endocrinol. Metab. 44 (1977) 264-272